Listen: Mark Lacy, CEO of Benchmark Research talks about Johnson & Johnson covid vaccine trials taking place in Sacramento and how you can participate.
Dr. Rusty Oshita said it does a great job preventing poor outcomes of COVID-19. Author: Mike Duffy Updated: 9:14 AM PST January 30, 2021
SACRAMENTO, Calif. A third COVID-19 vaccine, produced by Johnson & Johnson might soon be available for use in the United States.
One of the companies helping to test the vaccine, Benchmark Research, has a branch in Sacramento. Dr. Rusty Oshita is Benchmark’s principal investigator in Sacramento. In terms of the efficacy, what we know across the board, and that is all comers and across different continents that this study has persisted, about 86% efficacy, explained Dr. Oshita.
He said the research is ongoing, so final results will continue to vary.